Sort by
Refine Your Search
-
: https://www.ucl.ac.uk/bartlett/energy/research/shipping and www.shippingandoceans.com UCL is part of a consortium of eight universities leading on the maritime component of TransiT, a new UK research hub
-
or carbonation curing of cementitious materials. A good publication record, commensurate with the applicant’s career stage. What we offer Visit https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits to find out
-
(Neurogenetics lab) and in collaboration with Professor Joanne Ng (Genetic Therapy Accelerator Centre) and Professor Fiona Ducotterd (ARUK UCL Drug Discovery Institute). Biallelic AAGGG expansions in RFC1
-
well as the exciting opportunities this role presents, UCL also offer some great benefits. Visit https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits to find out more. Our commitment to Equality, Diversity and
-
As well as exciting opportunities this role presents, we also offer some great benefits, visit https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits to find out more. Our commitment to Equality
-
promoting equality, diversity and inclusion is essential. What we offer As well as exciting opportunities this role presents, we also offer some great benefits, visit https://www.ucl.ac.uk/work-at-ucl/rewards
-
, diversity and inclusion is essential. What we offer As well as the exciting opportunities this role presents, we also offer some great benefits, visit https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits
-
https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits to find out more. Our commitment to Equality, Diversity and Inclusion As London’s Global University, we know diversity fosters creativity and
-
, diversity and inclusion is essential. What we offer We also offer some great benefits, visit https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits to find out more. Our commitment to Equality, Diversity and
-
Professor Camille Carroll on the EJS ACT-PD trial. Identifying a disease-modifying therapy (DMT) for Parkinson’s disease (PD) is a major unmet need. The Edmond J Safra Accelerating Clinical Trials in